Literature DB >> 15448017

Innovations and challenges in renal cancer: consensus statement from the first international conference.

Michael B Atkins1, David E Avigan, Ronald M Bukowski, Richard W Childs, Janice P Dutcher, Tim G Eisen, Robert A Figlin, James H Finke, Robert C Flanigan, Daniel J George, S Nahum Goldberg, Michael S Gordon, Othon Iliopoulos, William G Kaelin, W Marston Linehan, Allan Lipton, Robert J Motzer, Andrew C Novick, Walter M Stadler, Bin Tean Teh, James C Yang, Laura King.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15448017     DOI： 10.1158/1078-0432.CCR-040720

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  8 in total

1.  Pancreatic metastases from renal cell carcinoma: the state of the art.

Authors:  Roberto Ballarin; Mario Spaggiari; Nicola Cautero; Nicola De Ruvo; Roberto Montalti; Cristina Longo; Anna Pecchi; Patrizia Giacobazzi; Giuseppina De Marco; Giuseppe D'Amico; Giorgio Enrico Gerunda; Fabrizio Di Benedetto
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

Review 2.  How were new medicines discovered?

Authors:  David C Swinney; Jason Anthony
Journal:  Nat Rev Drug Discov       Date:  2011-06-24       Impact factor: 84.694

3.  Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma.

Authors:  Alexander S Parker; Jeanette E Eckel-Passow; Daniel Serie; Tracy Hilton; Mansi Parasramka; Richard W Joseph; Kevin J Wu; John C Cheville; Bradley C Leibovich
Journal:  Eur Urol       Date:  2013-12-25       Impact factor: 20.096

4.  Pancreatic metastases: An increasing clinical entity.

Authors:  Alessandro Zerbi; Nicolò Pecorelli
Journal:  World J Gastrointest Surg       Date:  2010-08-27

5.  Nox4 is critical for hypoxia-inducible factor 2-alpha transcriptional activity in von Hippel-Lindau-deficient renal cell carcinoma.

Authors:  Jodi K Maranchie; Ye Zhan
Journal:  Cancer Res       Date:  2005-10-15       Impact factor: 12.701

6.  Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma.

Authors:  Alexander S Parker; Bradley C Leibovich; Christine M Lohse; Yuri Sheinin; Susan M Kuntz; Jeanette E Eckel-Passow; Michael L Blute; Eugene D Kwon
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

7.  Enhanced 15-lipoxygenase activity and elevated eicosanoid production in kidney tumor microenvironment contribute to the inflammation and immune suppression.

Authors:  Sergei Kusmartsev
Journal:  Oncoimmunology       Date:  2012-03-01       Impact factor: 8.110

8.  Resection of pancreatic metastatic renal cell carcinoma: experience and long-term survival outcome from a large center in China.

Authors:  Yang Ma; Jingrui Yang; Kai Qin; Yiran Zhou; Xiayang Ying; Fei Yuan; Minmin Shi; Jiabin Jin; Di Wang; Jiangning Gu; Dongfeng Cheng
Journal:  Int J Clin Oncol       Date:  2019-03-07       Impact factor: 3.402
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.